Preventive and protective properties of zingiber officinale (Ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: A brief review

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Li, Yiming ^a   Tran, Van H ^a   Duke, Colin C ^a   Roufogalis, Basil D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GINGER EXTRACT; GINGEROL; GLUCOSE; INSULIN; SHOGAOL;

DIABETES MELLITUS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG MECHANISM; DRUG SAFETY; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; LIPID METABOLISM; METABOLIC DISORDER; METABOLIC SYNDROME X; NAUSEA AND VOMITING; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW; STOMACH DISEASE;

EID: 84871388532     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/516870     Document Type: Review

References (84)

1. Danaei G., Finucane M. M., Lu Y., Singh G. M., Cowan M. J., Paciorek C. J., Lin J. K., Farzadfar F., Khang Y. H., Stevens G. A., Rao M., Ali M. K., Riley L. M., Robinson C. A., Ezzati M., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. The Lancet 2011 378 9785 31 40 2-s2.0-79959936188 10.1016/S0140-6736(11)60679-X
2. Shaw J. E., Sicree R. A., Zimmet P. Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 2010 87 1 4 14 2-s2.0-73749083481 10.1016/j.diabres.2009.10.007
3. Alberti K. G. M. M., Zimmet P. Z., Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998 15 7 539 553 2-s2.0-0031851293 10.1002/(SICI)1096- 9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S (Pubitemid 28319935)
4. Parillo M., Riccardi G., Diet composition and the risk of type 2 diabetes: epidemiological and clinical evidence. British Journal of Nutrition 2004 92 1 7 19 2-s2.0-3142554408 10.1079/BJN20041117 (Pubitemid 38961269)
5. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012 35 supplement 1 S64 S71 2-s2.0-84863847452 10.2337/dc12-s064
6. Ray K. K., Seshasai S. R. K., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., Erqou S., Sattar N., Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. The Lancet 2009 373 9677 1765 1772 2-s2.0-65649106228 10.1016/S0140-6736(09)60697-8
7. Holman R. R., Paul S. K., Bethel M. A., Matthews D. R., Neil H. A. W., 10-Year follow-up of intensive glucose control in type 2 diabetes. The New England Journal of Medicine 2008 359 15 1577 1589 2-s2.0-53749096863 10.1056/NEJMoa0806470
8. Ismail-Beigi F., Craven T., Banerji M. A., Basile J., Calles J., Cohen R. M., Cuddihy R., Cushman W. C., Genuth S., Grimm R. H., Hamilton B. P., Hoogwerf B., Karl D., Katz L., Krikorian A., O'Connor P., Pop-Busui R., Schubart U., Simmons D., Taylor H., Thomas A., Weiss D., Hramiak I., Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. The Lancet 2010 376 9739 419 430 2-s2.0-77955585592 10.1016/S0140-6736(10)60576-4
9. White B., Ginger: an overview. American Family Physician 2007 75 11 1689 1691 2-s2.0-34250764842 (Pubitemid 46954085)
10. Wang W. H., Wang Z. M., Studies of commonly used traditional medicine-ginger. Zhongguo Zhongyao Zazhi 2005 30 20 1569 1573 2-s2.0-33751290283
11. Chrubasik S., Pittler M. H., Roufogalis B. D., Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005 12 9 684 701 2-s2.0-23844530273 10.1016/j.phymed.2004.07.009 (Pubitemid 41169818)
12. Ali B. H., Blunden G., Tanira M. O., Nemmar A., Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and Chemical Toxicology 2008 46 2 409 420 2-s2.0-37349127807 10.1016/j.fct.2007.09.085 (Pubitemid 350297543)
13. Ojewole J. A. O., Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats. Phytotherapy Research 2006 20 9 764 772 2-s2.0-33748783056 10.1002/ptr.1952 (Pubitemid 44408657)
14. Akhani S. P., Vishwakarma S. L., Goyal R. K., Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. Journal of Pharmacy and Pharmacology 2004 56 1 101 105 2-s2.0-1042292667 10.1211/0022357022403 (Pubitemid 38195334)
15. Al-Amin Z. M., Thomson M., Al-Qattan K. K., Ali M., Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition 2006 96 4 660 666 2-s2.0-33947274715 10.1079/BJN20061849 (Pubitemid 46470189)
16. Abdulrazaq N. B., Cho M. M., Win N. N., Zaman R., Rahman M. T., Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats. British Journal of Nutrition 2011 108 07 1194 1201
17. Eckel R. H., Grundy S. M., Zimmet P. Z., The metabolic syndrome. The Lancet 2005 365 9468 1415 1428 2-s2.0-17144380822 10.1016/S0140-6736(05)66378-7 (Pubitemid 40523737)
18. Nammi S., Sreemantula S., Roufogalis B. D., Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2009 104 5 366 373 2-s2.0-64549145497 10.1111/j.1742-7843.2008.00362. x
19. Madkor H. R., Mansour S. W., Ramadan G., Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocin-nicotinamide diabetic rats. British Journal of Nutrition 2010 105 08 1210 1217 2-s2.0-78649789806 10.1017/S0007114510004927
20. Islam M. S., Choi H., Comparative effects of dietary ginger (Zingiber officinale) and garlic (Allium sativum) investigated in a type 2 diabetes model of rats. Journal of Medicinal Food 2008 11 1 152 159 2-s2.0-41349117455 10.1089/jmf.2007.634 (Pubitemid 351450508)
21. Singh A. B., Akanksha, Singh N., Maurya R., Srivastava A. K., Anti-hyperglycaemic, lipid lowering and anti-oxidant properties of [6]-gingerol in db/db mice. International Journal of Medicine and Medical Sciences 2009 1 12 536 544
22. Weidner M. S., Sigwart K., The safety of a ginger extract in the rat. Journal of Ethnopharmacology 2000 73 3 513 520 2-s2.0-0033697121 10.1016/S0378-8741(00)00340-8
23. Rani M. P., Krishna M. S., Padmakumari K. P., Raghu K. G., Sundaresan A., Zingiber officinale extract exhibits antidiabetic potential via modulating glucose uptake, protein glycation and inhibiting adipocyte differentiation: an in vitro study. Journal of the Science of Food and Agriculture 2012 92 9 1948 1955 2-s2.0-84861968349 10.1002/jsfa.5567
24. Li Y., Tran V. H., Duke C. C., Roufogalis B. D., Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes. Planta Medica 2012 78 14 1549 1555 2-s2.0-84867080446 10.1055/s-0032-1315041
25. Sekiya K., Ohtani A., Kusano S., Enhancement of insulin sensitivity in adipocytes by ginger. BioFactors 2004 22 1-4 153 156 2-s2.0-16244422631
26. Andallu B., Radhika B., Suryakantham V., Effect of aswagandha, ginger and mulberry on hyperglycemia and hyperlipidemia. Plant Foods for Human Nutrition 2003 58 3 1 7 2-s2.0-18644374720 (Pubitemid 40660236)
27. Bordia A., Verma S. K., Srivastava K. C., Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukotrienes and Essential Fatty Acids 1997 56 5 379 384 2-s2.0-0030978825 (Pubitemid 27208438)
28. 2 production. Phytochemistry 2005 66 13 1614 1635 2-s2.0-21844465655 10.1016/j.phytochem.2005.05.007 (Pubitemid 40950555)
29. 2 production. Phytochemistry 2004 65 13 1937 1954 2-s2.0-3242755759 10.1016/j.phytochem.2004. 06.008 (Pubitemid 38981684)
30. Priya Rani M., Padmakumari K. P., Sankarikutty B., Lijo Cherian O., Nisha V. M., Raghu K. G., Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress. International Journal of Food Sciences and Nutrition 2011 62 2 106 110 2-s2.0-79551503947 10.3109/09637486.2010.515565
31. Ranilla L. G., Kwon Y. I., Apostolidis E., Shetty K., Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresource Technology 2010 101 12 4676 4689 2-s2.0-77949264278 10.1016/j.biortech.2010.01.093
32. Platel K., Srinivasan K., Influence of dietary spices and their active principles on pancreatic digestive enzymes in albino rats. Die Nahrung 2000 44 1 42 46 2-s2.0-0034132584
33. Rossini A. A., Like A. A., Chick W. L., Studies of streptozotocin induced insulitis and diabetes. Proceedings of the National Academy of Sciences of the United States of America 1977 74 6 2485 2489 2-s2.0-0017648112 (Pubitemid 8112992)
34. Like A. A., Rossini A. A., Streptozotocin induced pancreatic insulitis: new model of diabetes mellitus. Science 1976 193 4251 415 417 2-s2.0-0017179001
35. Junod A., Lambert A. E., Stauffacher W., Renold A. E., Diabetogenic action of streptozotocin: relationship of dose to metabolic response. The Journal of Clinical Investigation 1969 48 11 2129 2139 2-s2.0-0014606996
36. Chakraborty D., Mukherjee A., Sikdar S., Paul A., Ghosh S., Khuda-Bukhsh A. R., [6]-Gingerol isolated from ginger attenuates sodium arsenite induced oxidative stress and plays a corrective role in improving insulin signaling in mice. Toxicology Letters 2012 210 1 34 43 2-s2.0-84856560488 10.1016/j.toxlet.2012.01.002
37. Heimes K., Feistel B., Verspohl E. J., Impact of the 5-HT3 receptor channel system for insulin secretion and interaction of ginger extracts. European Journal of Pharmacology 2009 624 1-3 58 65 2-s2.0-70350716167 10.1016/j.ejphar.2009.09.049
38. Abdel-Aziz H., Windeck T., Ploch M., Verspohl E. J., Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. European Journal of Pharmacology 2006 530 1-2 136 143 2-s2.0-29944440188 10.1016/j.ejphar.2005. 10.049 (Pubitemid 43040002)
39. Noipha K., Ratanachaiyavong S., Ninla-aesong P., Enhancement of glucose transport by selected plant foods in muscle cell line L6. Diabetes Research and Clinical Practice 2010 89 2 e22 e26 2-s2.0-77955092956 10.1016/j.diabres.2010. 04.021
40. Denis McGarry J., Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002 51 1 7 18 2-s2.0-0036092239 (Pubitemid 34517974)
41. Randle P. J., Garland P. B., Hales C. N., Newsholme E. A., The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. The Lancet 1963 281 7285 785 789 2-s2.0-50549202600
42. Roden M., Price T. B., Perseghin G., Petersen K. F., Rothman D. L., Cline G. W., Shulman G. I., Mechanism of free fatty acid-induced insulin resistance in humans. The Journal of Clinical Investigation 1996 97 12 2859 2865 2-s2.0-0029948212 (Pubitemid 26197099)
43. Fink R. I., Wallace P., Brechtel G., Olefsky J. M., Evidence that glucose transport is rate-limiting for in vivo glucose uptake. Metabolism 1992 41 8 897 902 2-s2.0-0026764502 10.1016/0026-0495(92)90174-9
44. Paranjpe P., Patki P., Patwardhan B., Ayurvedic treatment of obesity: a randomised double-blind, placebo-controlled clinical trial. Journal of Ethnopharmacology 1990 29 1 1 11 2-s2.0-0025247718 (Pubitemid 20115458)
45. Kamal R., Aleem S., Clinical evaluation of the efficacy of a combination of zanjabeel (Zingiber officinale) and amla (Emblica officinalis) in hyperlipidaemia. Indian Journal of Traditional Knowledge 2009 8 3 413 416
46. Nammi S., Kim M. S., Gavande N. S., Li G. Q., Roufogalis B. D., Regulation of low-density lipoprotein receptor and 3-hydroxy-3- methylglutaryl coenzyme A reductase expression by Zingiber officinale in the liver of high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2010 106 5 389 395 2-s2.0-77951073882 10.1111/j.1742-7843.2009.00497.x
47. Li X.-H., McGrath K. C.-Y., Nammi S., Heather A. K., Roufogalis B. D., Attenuation of liver pro-inflammatory responses by Zingiber officinale via inhibition of NF-kappa B activation in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2012 110 3 238 244 2-s2.0-84857363526 10.1111/j.1742-7843.2011.00791.x
48. Shanmugam K. R., Mallikarjuna K., Nishanth K., Kuo C. H., Reddy K. S., Protective effect of dietary ginger on antioxidant enzymes and oxidative damage in experimental diabetic rat tissues. Food Chemistry 2011 124 4 1436 1442 2-s2.0-77957017429 10.1016/j.foodchem.2010.07.104
49. Reddy A. C. P., Lokesh B. R., Studies on spice principles as antioxidants in the inhibition of lipid peroxidation of rat liver microsomes. Molecular and Cellular Biochemistry 1992 111 1-2 117 124 2-s2.0-0026711273
50. Shanmugam K. R., Ramakrishna C. H., Mallikarjuna K., Reddy K. S., The impact of ginger on kidney carbohydrate metabolic profiles in STZ induced diabetic rats. Asian Journal of Experimental Sciences 2009 23 1 127 134
51. Ramudu S. K., Korivi M., Kesireddy N., Lee L. C., Cheng I. S., Kuo C. H., Kesireddy S. R., Nephro-protective effects of a ginger extract on cytosolic and mitochondrial enzymes against streptozotocin (STZ)-induced diabetic complications in rats. The Chinese Journal of Physiology 2011 54 2 2-s2.0-79551542340 10.4077/CJP.2011.AMM006
52. Al-Qattan K., Thomson M., Ali M., Garlic (Allium sativum) and ginger (Zingiber officinale) attenuate structural nephropathy progression in streptozotocin-induced diabetic rats. e-SPEN 2008 3 2 e62 e71 2-s2.0-41349107986 10.1016/j.eclnm.2007.12.001
53. Elrokh E. S. M., Yassin N. A. Z., El-Shenawy S. M. A., Ibrahim B. M. M., Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. Inflammopharmacology 2010 18 6 309 315 2-s2.0-78651331272 10.1007/s10787-010-0053-5
54. Matsuda A., Wang Z., Takahashi S., Tokuda T., Miura N., Hasegawa J., Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life Sciences 2009 84 25-26 903 907 2-s2.0-67349138176 10.1016/j.lfs.2009.04.004
55. York D. A., Thomas S., Greenway F. L., Liu Z., Rood J. C., Effect of an herbal extract Number Ten (NT) on body weight in rats. Chinese Medicine 2007 2, article 10 2-s2.0-35448956894 10.1186/1749-8546-2-10
56. Goyal R. K., Kadnur S. V., Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006 77 3 160 163 2-s2.0-33646086967 10.1016/j.fitote.2006.01.005
57. Bhandari U., Kanojia R., Pillai K. K., Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. Journal of Ethnopharmacology 2005 97 2 227 230 2-s2.0-13544263392 10.1016/j.jep.2004.11.011 (Pubitemid 40222022)
58. Han L. K., Gong X. J., Kawano S., Saito M., Kimura Y., Okuda H., Antiobesity actions of Zingiber officinale Roscoe. Yakugaku Zasshi 2005 125 2 213 217 2-s2.0-17244368760 10.1248/yakushi.125.213 (Pubitemid 40628411)
59. Kaur G., Kulkarni S. K., Differential effect of polyherbal, antiobesity preparation, OB-200G in male and female mice and monosodium glutamate-treated rats. Indian Journal of Experimental Biology 2001 39 6 551 557 2-s2.0-0034983765 (Pubitemid 32516099)
60. Kaur G., Kulkarni S. K., Investigations on possible serotonergic involvement in effects of OB-200G (polyherbal preparation) on food intake in female mice. European Journal of Nutrition 2001 40 3 127 133 2-s2.0-0034793595 10.1007/s003940170013 (Pubitemid 32963503)
61. Fuhrman B., Rosenblat M., Hayek T., Coleman R., Aviram M., Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. Journal of Nutrition 2000 130 5 1124 1131 2-s2.0-0034011401 (Pubitemid 30233257)
62. Kaur G., Kulkarni S. K., Antiobesity effect of a polyherbal formulation, OB-200G in female rats fed on cafeteria and atherogenic diets. Indian Journal of Pharmacology 2000 32 5 294 299 2-s2.0-0033757782
63. Bhandari U., Sharma J. N., Zafar R., The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits. Journal of Ethnopharmacology 1998 61 2 167 171 2-s2.0-0032101966 10.1016/S0378-8741(98) 00026-9 (Pubitemid 28297907)
64. Tanabe M., Chen Y. D., Saito K., Kano Y., Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chemical and Pharmaceutical Bulletin 1993 41 4 710 713 2-s2.0-0027309319 (Pubitemid 23166144)
65. Shanmugam K. R., Mallikarjuna K., Kesireddy N., Sathyavelu Reddy K., Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin- induced diabetic rats. Food and Chemical Toxicology 2011 49 4 893 897 2-s2.0-79952439332 10.1016/j.fct.2010.12.013
66. Pollreisz A., Schmidt-Erfurth U., Diabetic cataract-pathogenesis, epidemiology and treatment. Journal of Ophthalmology 2010 2010 8 608751 10.1155/2010/608751
67. Kato A., Higuchi Y., Goto H., Kizu H., Okamoto T., Asano N., Hollinshead J., Nash R. J., Adachi I., Inhibitory effects of Zingiber officinale roscoe derived components on aldose reductase activity in vitro and in vivo. Journal of Agricultural and Food Chemistry 2006 54 18 6640 6644 2-s2.0-33748915431 10.1021/jf061599a (Pubitemid 44426940)
68. Saraswat M., Reddy P. Y., Muthenna P., Reddy G. B., Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications. British Journal of Nutrition 2009 101 11 1714 1721 2-s2.0-67649429389 10.1017/S0007114508116270
69. Saraswat M., Suryanarayana P., Reddy P. Y., Patil M. A., Balakrishna N., Reddy G. B., Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Molecular Vision 2010 16 1525 1537 2-s2.0-77955704177
70. Wang W., Li C. Y., Wen X. D., Li P., Qi L. W., Simultaneous determination of 6-gingerol, 8-gingerol, 10-gingerol and 6-shogaol in rat plasma by liquid chromatography-mass spectrometry: application to pharmacokinetics. Journal of Chromatography B 2009 877 8-9 671 679 2-s2.0-61349111478 10.1016/j.jchromb.2009. 01.021
71. Nakazawa T., Ohsawa K., Metabolism of [6]-gingerol in rats. Life Sciences 2002 70 18 2165 2175 2-s2.0-0037155495 10.1016/S0024-3205(01)01551-X (Pubitemid 34219466)
72. Pfeiffer E., Heuschmid F. F., Kranz S., Metzler M., Microsomal hydroxylation and glucuronidation of [6]-gingerol. Journal of Agricultural and Food Chemistry 2006 54 23 8769 8774 2-s2.0-33751304480 10.1021/jf062235l (Pubitemid 44797523)
73. Asami A., Shimada T., Mizuhara Y., Asano T., Takeda S., Aburada T., Miyamoto K. I., Aburada M., Pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe (Part I). Journal of Natural Medicines 2010 64 3 281 287 2-s2.0-77953553855 10.1007/s11418-010-0404-y
74. Jiang S. Z., Wang N. S., Mi S. Q., Plasma pharmacokinetics and tissue distribution of [6]-gingerol in rats. Biopharmaceutics and Drug Disposition 2008 29 9 529 537 2-s2.0-59849106109 10.1002/bdd.638
75. Zick S. M., Djuric Z., Ruffin M. T., Litzinger A. J., Normolle D. P., Alrawi S., Feng M. R., Brenner D. E., Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthyhuman subjects. Cancer Epidemiology Biomarkers and Prevention 2008 17 8 1930 1936 2-s2.0-54049152086 10.1158/1055-9965.EPI-07-2934
76. Yu Y., Zick S., Li X., Zou P., Wright B., Sun D., Examination of the pharmacokinetics of active ingredients of ginger in humans. BMC Biology 2011 13 3 417 426 2-s2.0-79957635677 10.1208/s12248-011-9286-5
77. Tiran D., Nausea and vomiting in pregnancy: safety and efficacy of self-administered complementary therapies. Complementary Therapies in Nursing and Midwifery 2002 8 4 191 196 2-s2.0-0036847373 10.1054/ctnm.2002.0651
78. Evira Warning label to be added on food supplements containing ginger as well as on ginger tea, and corresponding drink powders, 2012, http://www.evira.fi/portal/en/food/manufacture-and-sales/labelling/ warning-label-to-be-added-on-food-supplements-containing-ginger-as-well-as-on- ginger-tea-and-corresponding-drink-powders
79. Borrelli F., Capasso R., Aviello G., Pittler M. H., Izzo A. A., Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstetrics and Gynecology 2005 105 4 849 856 2-s2.0-15944420902 10.1097/01.AOG.0000154890.47642.23 (Pubitemid 40432207)
80. Portnoi G., Chng L. A., Karimi-Tabesh L., Koren G., Tan M. P., Einarson A., Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. American Journal of Obstetrics and Gynecology 2003 189 5 1374 1377 2-s2.0-0348011908 10.1067/S0002-9378(03)00649-5 (Pubitemid 37542175)
81. Weidner M. S., Sigwart K., Investigation of the teratogenic potential of a Zingiber officinale extract in the rat. Reproductive Toxicology 2001 15 1 75 80 2-s2.0-0035167493 10.1016/S0890-6238(00)00116-7 (Pubitemid 32057606)
82. Shalaby M. A., Hamowieh A. R., Safety and efficacy of Zingiber officinale roots on fertility of male diabetic rats. Food and Chemical Toxicology 2010 48 10 2920 2924 2-s2.0-77956342302 10.1016/j.fct.2010.07.028
83. Suekawa M., Ishige A., Yuasa K., Pharmacological studies on ginger. I. Pharmacological actions of pungent constituents, (6)-gingerol and (6)-shogaol. Journal of Pharmacobio-Dynamics 1984 7 11 836 848 2-s2.0-0021679209 (Pubitemid 15182635)
84. Rong X., Peng G., Suzuki T., Yang Q., Yamahara J., Li Y., A 35-day gavage safety assessment of ginger in rats. Regulatory Toxicology and Pharmacology 2009 54 2 118 123 2-s2.0-67349189944 10.1016/j.yrtph.2009.03.002